1 Sept 2020
We are releasing our unique off-target analysis service today. This novel service, enables de-risking drug development at an early stage utilizing the information about the composition of proteins in the human body, viruses, or diseases and extracts knowledge on how these proteins interact with drugs and other small molecules. Using artificial intelligence based algorithms, we can now search among hundreds of thousands of proteins and drugs for suitable associations to search and find unwanted protein targets that lead to side effects.
Read more: https://www.biorxiv.org/content/10.1101/2020.07.24.219071v1
Necessary cookies are absolutely essential for the website to function properly. This category only includes cookies that ensures basic functionalities and security features of the website. These cookies do not store any personal information.
Any cookies that may not be particularly necessary for the website to function and is used specifically to collect user personal data via analytics, ads, other embedded contents are termed as non-necessary cookies. It is mandatory to procure user consent prior to running these cookies on your website.